EHJ Editor-in-Chief (@ehj

EHJ Editor-in-Chief

3,726 posts

EHJ Editor-in-Chief

@ehj_ed

Official twitter account of the European Heart Journal Editor-in-Chief. Tweets by Prof. Filippo Crea and his team. #EHJ.

Rome, Italy

academic.oup.com/eurheartj

Joined January 2020

Pinned
EHJ Editor-in-Chief
@ehj_ed
11h
EHJ issue 47 - 22 is online: academic.oup.com/eurheartj/issu… Delve into ischaemic heart disease with a focus on sex and gender differences, coronary pathophysiology, and remodelling after myocardial infarction. @escardio @ESC_Journals #EHJ #cardiotwitter
00:00
742
EHJ Editor-in-Chief
@ehj_ed
Jun 21, 2023
Hypertension management in patients with cardiovascular comorbidities. A State-of-the-Art review just published in #EHJ. @escardio @ESC_Journals #CardioTwitter #hypertension academic.oup.com/eurheartj/arti…
75K
EHJ Editor-in-Chief
@ehj_ed
May 13, 2023
Takotsubo syndrome is a coronary microvascular disease: experimental evidence that abnormalities in flow regulation between the LV apex and base cause TTS. Read more in #EHJ @escardio @ESC_Journals #CardioTwitter #Takotsubo academic.oup.com/eurheartj/adva…
90K
EHJ Editor-in-Chief
@ehj_ed
Aug 13, 2023
Prevention and treatment of diuretic resistance in acute heart failure: when to use which combination of diuretics? academic.oup.com/eurheartj/adva… #HF #diuretics #prevention #DAPARESIST #cardiotwitter @escardio @ESC_Journals
45K
EHJ Editor-in-Chief
@ehj_ed
Sep 16, 2022
News from EMMY trial: in myocardial infarction, empagliflozin improves NT-proBNP and left ventricular ejection fraction! academic.oup.com/eurheartj/adva… #myocardial #infarction #empaglifozin #ehj #cardiotwitter @ESC_Journals @escardio
EHJ Editor-in-Chief
@ehj_ed
Aug 30, 2024
2024 #ESC #Guidelines for the management of atrial fibrillation developed in collaboration with @EACTS. Developed by the task force for the management of #AF of @escardio, with the special contribution of #EHRA: academic.oup.com/eurheartj/adva… @escardio @ESC_Journals @EACTS @ESOstroke
60K
EHJ Editor-in-Chief
@ehj_ed
Aug 29, 2020
This is my last Tweet as Editor-in-Chief of the EHJ: It is to say thank you and to alert you this issue on inflammation and fast track ESC papers online. Stay in touch, other Tweets will follow. #EHJ #ESC #Cardiotwitter @ESC_Journals @escardio ow.ly/CbJL50BcEZR
EHJ Editor-in-Chief
@ehj_ed
Aug 21, 2021
Iron supplementation in acute heart failure: energize your life ! doi.org/10.1093/eurhea… #cardiotwitter @ESC_Journals @escardio
EHJ Editor-in-Chief
@ehj_ed
Jul 21, 2022
Atrial septal defect in adulthood: a new paradigm for congenital heart disease. A State-of-the-Art Review in #EHJ @escardio @ESC_Journals #CardioTwitter academic.oup.com/eurheartj/arti…
EHJ Editor-in-Chief
@ehj_ed
Sep 8, 2021
Microvascular angina: quo tendimus? ow.ly/dzsG50G5NY1 #ischaemia #angina #coronary #microcirculation #CFR #CMD #cardiotwitter @escardio @ESC_Journals
EHJ Editor-in-Chief
@ehj_ed
Jan 26, 2022
What were the major advances in research in interventional cardiology in 2021? The year in cardiology series will tell you: #EHJ @ESC_Journals ow.ly/ew9150HB9pw
EHJ Editor-in-Chief
@ehj_ed
Jun 17, 2023
Statins revisited: therapeutic applications beyond lipid lowering? Read more in EHJ: doi.org/10.1093/eurhea… #statin #pleiotropiceffects #EHJ #cardiotwitter @ESC_Journals @escardio
47K
EHJ Editor-in-Chief
@ehj_ed
Mar 2, 2021
Digoxin or beta-blockers for atrial fibrillation with heart failure? RATE-AF trial showing that patient and public involvement in trial can generate a robust evidence-base to guide clinical management. #cardiotwitter, @ESC_Journals, @escardio, #AF. ow.ly/fBDu50DN183
EHJ Editor-in-Chief
@ehj_ed
Jun 29, 2022
2021 Impact Factors have been released & we are delighted to announce that our IF has increased to 35.855! We are very grateful to all of our authors, editors, reviewers and readers. THANK YOU! ❤️ Submit your best papers to #EHJ now! academic.oup.com/eurheartj @escardio